Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sartorius Stedim Bio    DIM   FR0000053266

Delayed Quote. Delayed Euronext Paris - 04/17 11:35:02 am
215.3 EUR   -0.23%
04/14 SARTORIUS STEDI : Dynamic First Quarter in 2015 | Forecast Revised U..
04/14 SARTORIUS STEDI : Sartoclear Dynamics®
04/10 SARTORIUS STEDI : ex-dividend day for annual dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201220132014201520162017
Sales544588684762829912
Operating income (EBITDA)119136161190219241
Operating profit (EBIT)87,2-120157183201
Pre-Tax Profit (EBT)--105150173194
Net income57,967,572,5104121137
EPS ( €)3,704,904,726,707,728,87
Dividend per Share ( €)1,101,201,301,481,821,88
Yield0,51%0,56%0,60%0,69%0,84%0,87%
Announcement Date01/29/2013
08:59am
01/28/2014
06:00am
01/27/2015
04:00pm
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201220132014201520162017
Debt116-87,430,621,08,45
Finance------
Operating income (EBITDA)119136161190219241
Leverage
(Debt/EBITDA)
0,98x-0,54x0,16x0,10x0,04x
Capital Expenditure38,829,347,162,259,656,0
Book Value Per Share (BVPS)28,2 €-34,7 €37,5 €46,7 €54,0 €
Cash Flow per Share2,87 €-7,25 €8,75 €10,2 €11,5 €
Announcement Date01/29/2013
08:59am
01/28/2014
06:00am
01/27/2015
04:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 3 307 M€ -
Entreprise Value (EV) 3 337 M€ 3 328 M€
Valuation 2015e 2016e
PER (Price / EPS) 32,2x 27,9x
Capitalization / Revenue 4,34x 3,99x
EV / Revenue 4,38x 4,01x
EV / EBITDA 17,6x 15,2x
Yield (DPS / Price) 0,69% 0,84%
Price to book (Price / BVPS) 5,74x 4,61x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 20,5% 22,0%
operating Leverage (Delta EBIT / Delta Sales) 2,63x 1,88x
Net Margin (Net Profit / Revenue) 13,7% 14,5%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 17,9% 17,7%
Rate of Dividend 22,1% 23,5%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,17% 7,19%
Cash Flow / Sales (Taux d'autofinancement) 17,6% 18,8%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,16x 0,10x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF